SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-20-000548
Filing Date
2020-01-13
Accepted
2020-01-13 17:09:19
Documents
1
Period of Report
2020-01-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1324
  Complete submission text file 0001437749-20-000548.txt   3044
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DIFFUSION PHARMACEUTICALS INC. 1317 CARLTON AVENUE, SUITE 200 CHARLOTTESVILLE VA 22902
Business Address
Cobuzzi Robert Joseph Jr. (Reporting) CIK: 0001799838 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37942 | Film No.: 20524317